Clinical Trials Browser

Phase 1/2 × Leukemia, Myelomonocytic, Chronic × Lenalidomide × Clear all

NCT00352001 2018-09-19

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes

Phase 1/2 Completed

37 enrolled 14 charts

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT01368757 2015-03-09

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic